FMP

FMP

Enter

KZIA - Kazia Therapeutics L...

Financial Summary of Kazia Therapeutics Limited(KZIA), Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. I

photo-url-https://financialmodelingprep.com/image-stock/KZIA.png

Kazia Therapeutics Limited

KZIA

NASDAQ

Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia.

0.63 USD

-0.0286 (-4.54%)

About

ceo

Dr. John Edwin Friend II, M.D.

sector

Healthcare

industry

Biotechnology

exchange

NASDAQ

Description

Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia.

CIK

0001075880

ISIN

US48669G1058

CUSIP

48669G105

Address

Three International Towers

Phone

1300 787 272

Country

AU

Employee

9

IPO Date

Jan 6, 1999

Summary

CIK

0001075880

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

48669G105

ISIN

US48669G1058

Country

AU

Price

0.63

Beta

2.13

Volume Avg.

12.73M

Market Cap

12.94M

Shares

-

52-Week

0.19-1.58

DCF

0.13

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-1.66

P/B

-

Website

https://www.kaziatherapeutics.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest KZIA News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep